FNY Investment Advisers’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Buy
140
+10
+8% +$54 ﹤0.01% 874
2026
Q1
$0 Buy
130
+100
+333% +$598 ﹤0.01% 788
2025
Q4
$0 Buy
+30
New +$197 ﹤0.01% 957
2022
Q3
Sell
-75
Closed 657
2022
Q2
$0 Sell
75
-25
-25% -$349 ﹤0.01% 711
2022
Q1
$2K Buy
+100
New +$2.44K ﹤0.01% 611
2021
Q1
Sell
-200
Closed -$4K 788
2020
Q4
$4K Buy
+200
New +$3.73K ﹤0.01% 659

Other funds holding BHC

FNY Investment Advisers's BHC Position: Q2 2026 in Review

FNY Investment Advisers increased its Bausch Health (BHC) stake by 7.7% in Q2 2026, buying an estimated $54 and bringing the position to 140 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #874.

FNY Investment Advisers first reported a position in BHC in Q4 2020 and has held it in 6 quarters since. The position peaked at $4K in Q4 2020. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • FNY Investment Advisers held 140 shares of Bausch Health worth $0 as of Q2 2026.
  • FNY Investment Advisers bought 10 Bausch Health shares in Q2 2026, an estimated $54.
  • Bausch Health made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #874 holding.
  • FNY Investment Advisers first reported a position in Bausch Health in Q4 2020 and has held it in 6 quarters since.
  • FNY Investment Advisers's Bausch Health position peaked at $4K in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.